Literature DB >> 8485505

Stability of cisplatin in sodium chloride 0.9% intravenous solution related to the container's material.

M Pujol Cubells1, J Prat Aixela, V Girona Brumos, S Duran Pou, M Villaronga Flaque.   

Abstract

The stability of cisplatin in sodium chloride 0.9% intravenous solutions contained in glass bottles, polyvinyl chloride bags, polyethylene and polypropylene containers was studied over two weeks. The solubility of cisplatin at 4 degrees C was also studied for possible precipitation. The type of container had no effect on cisplatin decomposition. No precipitation at 4 degrees C was observed within the time period studied.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8485505     DOI： 10.1007/bf02116167

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN： 0928-1231


  6 in total

1.  Platinum complexes: a new class of antineoplastic agents.

Authors:  F K Leh; W Wolf
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

2.  cis-Dichlorodiammineplatinum(II) stability in aqueous vehicles: an alternate view.

Authors:  A J Repta; D F Long; A A Hincal
Journal:  Cancer Treat Rep       Date:  1979-02

3.  Stability of cisplatin in aqueous solution.

Authors:  R F Greene; D C Chatterji; P K Hiranaka; J F Gallelli
Journal:  Am J Hosp Pharm       Date:  1979-01

4.  Coordination complexes of platinum as antitumor agents.

Authors:  R J Speer; H Ridgway; L M Hall; D P Stewart; K E Howe; D Z Lieberman; A D Newman; J M Hill
Journal:  Cancer Chemother Rep       Date:  1975 May-Jun

5.  Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.

Authors:  Y W Cheung; J C Cradock; B R Vishnuvajjala; K P Flora
Journal:  Am J Hosp Pharm       Date:  1987-01

6.  Dosage schedules of antimicrobial agents: a historical review.

Authors:  C M Kunin
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb
  6 in total
  7 in total

1.  Effect of sodium chloride on efficiency of cisplatinum dissolved in dimethyl sulfoxide: an in vitro study.

Authors:  Seyed Kazem Bagherpour Doun; Sohrab Halal Khor; Dardi Qujeq; Hasan Ebrahimi Shahmabadi; Seyed Ebrahim Alavi; Fatemeh Movahedi; Azim Akbarzadeh
Journal:  Indian J Clin Biochem       Date:  2013-07-10

2.  Effects of solvents on in vitro potencies of platinum compounds.

Authors:  Yong Weon Yi; Insoo Bae
Journal:  DNA Repair (Amst)       Date:  2011-10-05

3.  The Interactions between L-tyrosine based nanoparticles decorated with folic acid and cervical cancer cells under physiological flow.

Authors:  Andrew J Ditto; Kush N Shah; Nikki K Robishaw; Matthew J Panzner; Wiley J Youngs; Yang H Yun
Journal:  Mol Pharm       Date:  2012-09-28       Impact factor: 4.939

4.  In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.

Authors:  Maryam Sadat Ashrafzadeh; Azim Akbarzadeh; Amir Heydarinasab; Mehdi Ardjmand
Journal:  Int J Nanomedicine       Date:  2020-09-23

5.  Evaluation of Cisplatin Efficacy on HepG2 and E. coli Cells under Acidic Conditions

Authors:  Faezeh Babaei; Hasan Ebrahimi Shahmabadi; Mohammad Reza Rajabi; Hamed Haddad Kashani; Fatemeh Izadpanah
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

6.  Effect of different shielding conditions on the stability of Cisplatin.

Authors:  Tomoya Abe; Daigo Matsumoto; Toshiaki Nakayama; Yukinari Shimazaki; Atsunobu Sagara; Dan Kanehira; Takuya Azechi; Fumiaki Sato; Hiroyasu Sakai; Tetsuro Yumoto; Junzo Kamei
Journal:  J Pharm Health Care Sci       Date:  2020-03-11

7.  The physical and chemical stability of cisplatin (Teva) in concentrate and diluted in sodium chloride 0.9%.

Authors:  Agnieszka Karbownik; Edyta Szałek; Hanna Urjasz; Aleksandra Głęboka; Emilia Mierzwa; Edmund Grześkowiak
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.